483
Sandoz GmbHFDA 483 - Sandoz GmbH - January 12, 2023
Record Details
An FDA inspection of Sandoz GmbH in Langkampfen, Austria, a pharmaceutical manufacturer, revealed two significant deficiencies. The firm failed to adequately establish procedures for verifying the effectiveness of corrective and preventive actions (CAPA) and for properly investigating product complaints, specifically concerning malfunctions of Hyrimoz. These issues indicate a moderate level of non-compliance with quality system requirements.
View Company Profile
ID · 16d4f5ca-64b0-4d7e-9783-321517445f81
Other documents for Sandoz GmbH
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.